DEF 14A

Company

Immunovant, Inc.

Filed

June 30, 2022

Period of Report

March 31, 2022

Accession Number

0001764013-22-000066

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →